126 related articles for article (PubMed ID: 36457561)
1. Navigated 577-nm subthreshold micropulse retinal laser treatment for peripapillary pachychoroid syndrome.
Iovino C; Di Iorio V; Paolercio L; Giordano C; Testa F; Simonelli F
Am J Ophthalmol Case Rep; 2022 Dec; 28():101757. PubMed ID: 36457561
[TBL] [Abstract][Full Text] [Related]
2. PERIPAPILLARY PACHYCHOROID SYNDROME.
Phasukkijwatana N; Freund KB; Dolz-Marco R; Al-Sheikh M; Keane PA; Egan CA; Randhawa S; Stewart JM; Liu Q; Hunyor AP; Kreiger A; Nagiel A; Lalane R; Rahimi M; Lee WK; Jampol LM; Sarraf D
Retina; 2018 Sep; 38(9):1652-1667. PubMed ID: 29135799
[TBL] [Abstract][Full Text] [Related]
3. Peripapillary pachychoroid syndrome successfully treated with topical prednisolone acetate 1% drops.
Azizalrahman LA; Almousa AN; Al Adel F; AlBloushi AF
Saudi J Ophthalmol; 2024; 38(1):89-91. PubMed ID: 38628407
[TBL] [Abstract][Full Text] [Related]
4. Peripapillary retinal neovascularization and vitreous hemorrhage secondary to peripapillary pachychoroid syndrome.
Zhioua Braham I; Boukari M; Maalej R; Mili I; Zhioua R
Am J Ophthalmol Case Rep; 2024 Mar; 33():101961. PubMed ID: 38374948
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
[TBL] [Abstract][Full Text] [Related]
6. 532-nm Subthreshold Micropulse Laser for the Treatment of Chronic Central Serous Retinopathy.
Sousa K; Calvão-Santos G; João M; Gomes N; Falcão M
Clin Ophthalmol; 2020; 14():525-531. PubMed ID: 32158185
[TBL] [Abstract][Full Text] [Related]
7. OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy.
Zheng F; He J; Su Z; Liu Y; Xu Y; Liu L; Ye P
BMC Ophthalmol; 2022 Jun; 22(1):252. PubMed ID: 35668416
[TBL] [Abstract][Full Text] [Related]
8. Peripapillary pachychoroid neovasculopathy: A novel entity.
Montero Hernández J; Remolí Sargues L; Monferrer Adsuara C; Castro Navarro V; Navarro Palop C; Cervera Taulet E
Eur J Ophthalmol; 2022 Jan; 32(1):NP149-NP153. PubMed ID: 32842763
[TBL] [Abstract][Full Text] [Related]
9. POTENTIAL TREATMENT FOR PERIPAPILLARY PACHYCHOROID SYNDROME.
Pothof AB; Fernández-Avellaneda P; Behar-Cohen F; Martinez Ciriano JP; Yzer S
Retin Cases Brief Rep; 2023 Jul; 17(4):425-429. PubMed ID: 37364202
[TBL] [Abstract][Full Text] [Related]
10. Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.
Prasuhn M; Miura Y; Tura A; Rommel F; Kakkassery V; Sonntag S; Grisanti S; Ranjbar M
J Clin Med; 2021 May; 10(11):. PubMed ID: 34072472
[TBL] [Abstract][Full Text] [Related]
11. Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial.
Zhou L; Lai K; Jin L; Huang C; Xu F; Gong Y; Li L; Zhu Z; Lu L; Jin C
Front Med (Lausanne); 2021; 8():682264. PubMed ID: 34336888
[No Abstract] [Full Text] [Related]
12. Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema.
Toto L; D'Aloisio R; Quarta A; Libertini D; D'Onofrio G; De Nicola C; Romano A; Mastropasqua R
J Clin Med; 2022 Sep; 11(17):. PubMed ID: 36079129
[TBL] [Abstract][Full Text] [Related]
13. ACQUIRED VITELLIFORM LESIONS: A Novel Finding in Eyes with Peripapillary Pachychoroid Syndrome.
Barequet D; Iglicki M; Meshi A; Loewenstein A; Goldstein M; Zur D
Retina; 2022 May; 42(5):949-956. PubMed ID: 35019889
[TBL] [Abstract][Full Text] [Related]
14. [Micropulse laser treatment of complicated forms of sclerogenic macular degeneration].
Melikhova MV; Gatsu MV
Vestn Oftalmol; 2022; 138(2):23-30. PubMed ID: 35488559
[TBL] [Abstract][Full Text] [Related]
15. Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.
Amoroso F; Pedinielli A; Cohen SY; Jung C; Chhablani J; Astroz P; Colantuono D; Semoun O; Capuano V; Souied EH; Miere A
Eur J Ophthalmol; 2022 Sep; 32(5):2810-2818. PubMed ID: 34846180
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the Lamina Cribrosa Are Associated with Peripapillary Retinoschisis in Glaucoma and Pachychoroid Spectrum Disease.
Lee JH; Park HY; Baek J; Lee WK
Ophthalmology; 2016 Oct; 123(10):2066-76. PubMed ID: 27506483
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser.
van Rijssen TJ; van Dijk EHC; Scholz P; Breukink MB; Dijkman G; Peters PJH; Tsonaka R; Keunen JEE; MacLaren RE; Hoyng CB; Downes SM; Fauser S; Boon CJF
Acta Ophthalmol; 2021 Nov; 99(7):805-811. PubMed ID: 33565230
[TBL] [Abstract][Full Text] [Related]
18. Subthreshold Micropulse Laser for Long-Lasting Submacular Fluid after Rhegmatogeous Retinal Detachment Surgery.
Esposti G; Luigi Esposti P; Costantino F; Zappalà D; Pinna A; Fruschelli M
J Ophthalmic Vis Res; 2022; 17(3):390-396. PubMed ID: 36160097
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of subthreshold micropulse laser for chronic central serous chorioretinopathy: A meta-analysis.
Li X; Long H; Hu Q
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102931. PubMed ID: 35636735
[TBL] [Abstract][Full Text] [Related]
20. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
